- In March 2024, Sanofi Consumer Health entered into a strategic partnership with Alliance Healthcare and Phoenix Healthcare Distribution to enhance the availability of its key products in the United Kingdom. This collaboration aims to streamline the supply chain process, ensuring better stock availability of products such as Allevia, Buscopan, Dulcolax, and Phenergan in pharmacies across the U.K. The partnership also focuses on increasing operational efficiency and expanding the company’s market reach
- In January 2024, Bayer AG’s consumer health division launched “The Gut Gap” campaign in the U.S. to raise awareness about the prevalent issues of stress and constipation, particularly among American women. The initiative, backed by a commissioned survey, highlights the need for solutions such as MiraLax to address constipation. This campaign aims to amplify product outreach and provide support for women experiencing digestive discomfort
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Normal-transit constipation, Slow-transit constipation and Others), Therapy Type (Pharmacological Therapy and Non-pharmacological Therapy), Treatment Type (Medication and Surgery), Drugs (Serotonin-4 (5-Ht4) Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants and Others),Route of Administration (Oral and Injectable), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others) – Industry Trends and Forecast to 2032
.
The Global Chronic Idiopathic Constipation Treatment Market size was valued at USD 3.50 USD Billion in 2024.
The Global Chronic Idiopathic Constipation Treatment Market is projected to grow at a CAGR of 6.53% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
